Cargando…

Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]

Service users within the NHS are increasingly being asked to participate in clinical research. In Liverpool Women's NHS Foundation Trust, approximately 35% of women take part in research during their pregnancy. For many studies the consent process is simple; information is provided and signed c...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernon, Gillian, Alfirevic, Zarko, Weeks, Andrew
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1481528/
https://www.ncbi.nlm.nih.gov/pubmed/16689989
http://dx.doi.org/10.1186/1745-6215-7-13
_version_ 1782128255443140608
author Vernon, Gillian
Alfirevic, Zarko
Weeks, Andrew
author_facet Vernon, Gillian
Alfirevic, Zarko
Weeks, Andrew
author_sort Vernon, Gillian
collection PubMed
description Service users within the NHS are increasingly being asked to participate in clinical research. In Liverpool Women's NHS Foundation Trust, approximately 35% of women take part in research during their pregnancy. For many studies the consent process is simple; information is provided and signed consent is given. There is a difficulty, however, with obtaining informed consent from women in pregnancy who become eligible only when they develop unforeseen complications, especially when they occur acutely. The problem is compounded with women in labour who may be frightened, vulnerable, in pain, under the effect of opiate analgesia, or all of the above. If research to improve the care of these women is to continue, then special consent procedures are needed. These procedures must ensure that the woman's autonomy is protected whilst recognising that women under these circumstances vary enormously, both in their desire for information and their ability to comprehend it. This paper will discuss the obtaining of consent in this situation, and describe an information and consent pathway for intrapartum research which has been developed in collaboration with consumer groups as a way in which these issues can be tackled.
format Text
id pubmed-1481528
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14815282006-06-22 Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] Vernon, Gillian Alfirevic, Zarko Weeks, Andrew Trials Commentary Service users within the NHS are increasingly being asked to participate in clinical research. In Liverpool Women's NHS Foundation Trust, approximately 35% of women take part in research during their pregnancy. For many studies the consent process is simple; information is provided and signed consent is given. There is a difficulty, however, with obtaining informed consent from women in pregnancy who become eligible only when they develop unforeseen complications, especially when they occur acutely. The problem is compounded with women in labour who may be frightened, vulnerable, in pain, under the effect of opiate analgesia, or all of the above. If research to improve the care of these women is to continue, then special consent procedures are needed. These procedures must ensure that the woman's autonomy is protected whilst recognising that women under these circumstances vary enormously, both in their desire for information and their ability to comprehend it. This paper will discuss the obtaining of consent in this situation, and describe an information and consent pathway for intrapartum research which has been developed in collaboration with consumer groups as a way in which these issues can be tackled. BioMed Central 2006-05-11 /pmc/articles/PMC1481528/ /pubmed/16689989 http://dx.doi.org/10.1186/1745-6215-7-13 Text en Copyright © 2006 Vernon et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Vernon, Gillian
Alfirevic, Zarko
Weeks, Andrew
Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]
title Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]
title_full Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]
title_fullStr Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]
title_full_unstemmed Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]
title_short Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]
title_sort issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the release trial [isrctn13204258]
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1481528/
https://www.ncbi.nlm.nih.gov/pubmed/16689989
http://dx.doi.org/10.1186/1745-6215-7-13
work_keys_str_mv AT vernongillian issuesofinformedconsentforintrapartumtrialsasuggestedconsentpathwayfromtheexperienceofthereleasetrialisrctn13204258
AT alfireviczarko issuesofinformedconsentforintrapartumtrialsasuggestedconsentpathwayfromtheexperienceofthereleasetrialisrctn13204258
AT weeksandrew issuesofinformedconsentforintrapartumtrialsasuggestedconsentpathwayfromtheexperienceofthereleasetrialisrctn13204258